NeoPhore's small molecule drugs pipeline gets additional &#x

A company building a pipeline of small molecule drugs targeting novel proteins across the DNA mismatch repair (pathway) has announced a further extension to its series B financing round.

Related Keywords

Boston , Massachusetts , United States , Italy , Intesa Sanpaolo , Stefano Buono , Matthew Baker , Simon Fiduciaria , Robert James , B Future Health Fund , Ersel Group , Neophore Limited , Sixth Element Capital , Claris Ventures , Astellas Venture Management , Bfuture Health Fund , Markets Amp Regulations , Drug Delivery , Ingredients , Clinical Development , Atient Centricity , Pis Active Pharmaceutical Ingredients , Regulations , Small Molecule Drugs , Pharmaceutical Industry , Novel Protein , Seriesb Funding Round , Immuno Oncology ,